BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

25505

541304

INDOUS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

INDO US BIOTECH LTD performance

Today’s low

Today’s high

₹ 147.03 ₹ 154.77
₹ 147.44

52 week low

52 week high

₹ 145.00 ₹ 388.40
₹ 147.44

Open Price

₹ 154.77

Prev. Close

₹ 154.77

Volume (Shares)

2170.00

Total traded value

₹ 3.19

Upper Circuit

₹ 162.50

Lower Circuit

₹ 147.03

info

INDO US BIOTECH LTD Share Price Update

As of the latest trading session, INDO US BIOTECH LTD share price is currently at ₹ 147.03, which is down by ₹ -7.74 from its previous closing. Today, the stock has fluctuated between ₹ 147.03 and ₹ 154.77. Over the past year, INDO US BIOTECH LTD has achieved a return of -47.10 %. In the last month alone, the return has been -0.72 %. Read More...

INDO US BIOTECH LTD fundamentals


  • Market cap (Cr)

    134.77

  • P/E Ratio (TTM)

    18.54

  • Beta

    1.10

  • Book Value / share

    35.03

  • Return on equity

    14.07%

  • EPS (TTM)

    8.37

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    5.05

info icon alternate text
  • Market cap (Cr)

    141.12

  • P/E Ratio (TTM)

    18.54

  • Beta

    0.80

  • Book Value / share

    35.03

  • Return on equity

    14.07%

  • EPS (TTM)

    8.37

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    5.05

info icon alternate text

INDO US BIOTECH LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 23.56
Operating Expense 18.56
Net Profit 5.05
Net Profit Margin (%) 21.43
Earnings Per Share (EPS) 2.52
EBITDA 5.56
Effective Tax Rate (%) -0.79
Particulars SEP 2024 (Values in Cr)
Revenue 22.17
Operating Expense 17.75
Net Profit 4.36
Net Profit Margin (%) 19.66
Earnings Per Share (EPS) 2.16
EBITDA 5.15
Effective Tax Rate (%) 2.02
Particulars JUN 2024 (Values in Cr)
Revenue 24.72
Operating Expense 21.56
Net Profit 3.17
Net Profit Margin (%) 12.82
Earnings Per Share (EPS) 1.58
EBITDA 3.72
Effective Tax Rate (%) 0.62
Particulars MAR 2024 (Values in Cr)
Revenue 37.88
Operating Expense 33.79
Net Profit 4.21
Net Profit Margin (%) 11.11
Earnings Per Share (EPS) 2.10
EBITDA 5.49
Effective Tax Rate (%) 3.88
Particulars DEC 2023 (Values in Cr)
Revenue 22.11
Operating Expense 18.43
Net Profit 3.68
Net Profit Margin (%) 16.64
Earnings Per Share (EPS) 1.84
EBITDA 4.31
Effective Tax Rate (%) 1.86
Particulars MAR 2024 (Values in Cr)
Revenue 72.84
Operating Expense 64.35
Net Profit 8.25
Net Profit Margin (%) 11.32
Earnings Per Share (EPS) 4.11
EBITDA 11.11
Effective Tax Rate (%) 6.25
Particulars MAR 2023 (Values in Cr)
Revenue 61.74
Operating Expense 54.37
Net Profit 7.24
Net Profit Margin (%) 11.72
Earnings Per Share (EPS) 7.51
EBITDA 9.40
Effective Tax Rate (%) 2.02
Particulars MAR 2022 (Values in Cr)
Revenue 50.05
Operating Expense 44.75
Net Profit 5.27
Net Profit Margin (%) 10.52
Earnings Per Share (EPS) 5.75
EBITDA 7.11
Effective Tax Rate (%) 4.00
Particulars MAR 2021 (Values in Cr)
Revenue 40.09
Operating Expense 36.00
Net Profit 5.10
Net Profit Margin (%) 12.72
Earnings Per Share (EPS) 8.40
EBITDA 5.55
Effective Tax Rate (%) -23.48
Particulars MAR 2020 (Values in Cr)
Revenue 39.76
Operating Expense 36.89
Net Profit 2.53
Net Profit Margin (%) 6.36
Earnings Per Share (EPS) 4.18
EBITDA 3.96
Effective Tax Rate (%) 11.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.01
ROE % 16.91
ROCE % 15.11
Total Debt to Total Equity 0.41
EBITDA Margin 13.92
Particulars MAR 2021 (Values in Cr)
Book Value / Share 35.17
ROE % 25.94
ROCE % 17.20
Total Debt to Total Equity 0.53
EBITDA Margin 13.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.10
ROE % 15.39
ROCE % 14.56
Total Debt to Total Equity 0.52
EBITDA Margin 9.98
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.29
ROE % 14.07
ROCE % 14.18
Total Debt to Total Equity 0.22
EBITDA Margin 15.27
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.35
ROE % 15.51
ROCE % 14.37
Total Debt to Total Equity 0.26
EBITDA Margin 15.24
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.41
ROE % 17.35
ROCE % 15.50
Total Debt to Total Equity 0.40
EBITDA Margin 14.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share 35.50
ROE % 26.86
ROCE % 17.85
Total Debt to Total Equity 0.53
EBITDA Margin 13.89
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.10
ROE % 16.68
ROCE % 16.13
Total Debt to Total Equity 0.49
EBITDA Margin 9.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 55.61
Total Liabilities 55.61
Total Equity 38.50
Share Outstanding 9166700
Price to Book Ratio 1.59
Return on Assets (%) 9.10
Return on Capital (%) 9.86
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 43.70
Total Liabilities 43.70
Total Equity 21.34
Share Outstanding 6067990
Price to Book Ratio 0.92
Return on Assets (%) 11.21
Return on Capital (%) 14.89
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 34.69
Total Liabilities 34.69
Total Equity 16.44
Share Outstanding 6067990
Price to Book Ratio 1.89
Return on Assets (%) 7.30
Return on Capital (%) 10.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 84.45
Total Liabilities 84.45
Total Equity 62.74
Share Outstanding 20052000
Price to Book Ratio 7.09
Return on Assets (%) 9.77
Return on Capital (%) 10.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.18
Total Assets 69.46
Total Liabilities 69.46
Total Equity 54.49
Share Outstanding 10026000
Price to Book Ratio 3.91
Return on Assets (%) 10.42
Return on Capital (%) 10.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 55.57
Total Liabilities 55.57
Total Equity 38.87
Share Outstanding 9166700
Price to Book Ratio 1.59
Return on Assets (%) 9.42
Return on Capital (%) 10.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 43.67
Total Liabilities 43.67
Total Equity 21.54
Share Outstanding 6067990
Price to Book Ratio 0.92
Return on Assets (%) 11.67
Return on Capital (%) 15.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 34.69
Total Liabilities 34.69
Total Equity 16.44
Share Outstanding 6067990
Price to Book Ratio 1.89
Return on Assets (%) 7.30
Return on Capital (%) 10.43
Particulars MAR 2022 (Values in Cr)
Net Income 5.31
Cash from Operations 3.08
Cash from Investing -5.44
Cash from Financing 2.65
Net change in Cash -0.08
Free Cash Flow 7.05
Particulars MAR 2021 (Values in Cr)
Net Income 3.92
Cash from Operations 0.29
Cash from Investing -1.77
Cash from Financing 1.55
Net change in Cash -0.06
Free Cash Flow 2.24
Particulars MAR 2020 (Values in Cr)
Net Income 2.86
Cash from Operations -0.81
Cash from Investing -0.56
Cash from Financing 1.52
Net change in Cash 0.11
Free Cash Flow -0.41
Particulars MAR 2024 (Values in Cr)
Net Income 8.80
Cash from Operations -4.27
Cash from Investing 4.27
Cash from Financing 1.21
Net change in Cash 0.90
Free Cash Flow -1.66
Particulars MAR 2023 (Values in Cr)
Net Income 7.38
Cash from Operations 0.84
Cash from Investing -6.67
Cash from Financing 6.28
Net change in Cash 0.14
Free Cash Flow 2.66
Particulars MAR 2022 (Values in Cr)
Net Income 5.48
Cash from Operations 3.29
Cash from Investing -5.40
Cash from Financing 2.41
Net change in Cash -0.08
Free Cash Flow 7.26
Particulars MAR 2021 (Values in Cr)
Net Income 4.12
Cash from Operations 0.36
Cash from Investing -1.75
Cash from Financing 1.46
Net change in Cash -0.06
Free Cash Flow 2.27
Particulars MAR 2020 (Values in Cr)
Net Income 2.86
Cash from Operations -0.81
Cash from Investing -0.56
Cash from Financing 1.52
Net change in Cash 0.11
Free Cash Flow -0.41
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5469.20 60.56 41.03 131735.69 4506.50 / 6473.10
NESTLE INDIA LIMITED 2387.45 74.96 57.40 230187.70 2115.00 / 2777.00
FOODS & INNS LIMITED 89.63 27.16 1.28 658.02 75.20 / 165.70
HINDUSTAN UNILEVER LTD. 2322.55 52.36 11.04 545704.32 2136.00 / 3034.50
MILKFOOD LTD. 86.03 34.97 1.19 209.73 61.25 / 215.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5469.20 62.08 47.49 131735.69 4506.50 / 6473.10
COLGATE PALMOLIVE LTD. 2645.25 49.22 43.53 71947.00 2324.00 / 3893.00
NESTLE INDIA LIMITED 2387.45 74.31 55.90 230187.70 2115.00 / 2777.00
FOODS & INNS LIMITED 89.63 26.13 1.27 658.02 75.20 / 165.70

INDO US BIOTECH LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
147.44 -4.73 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 163.40
  • 26 Days 168.30
  • 10 Days 165.00
  • 50 Days 181.40
  • 12 Days 165.10
  • 100 Days 209.40
  • 20 Days 166.20
  • 200 Days 236.30
159.32 PIVOT

First Support

149.99

First Resistance

164.10

Second Support

145.21

Second Resistance

173.43

Third Support

135.88

Third Resistance

178.21

RSI

38.04

ADX

12.54

MACD

-3.17

Williams % R

-83.99

Commodity Channel Index (CCI)

-29.39

Date

-

Week

0.0

Same Day

0.0

Month

0.0

1 Year

1.11

3 Year

1.12

Over 1 Month

-0.72%

down

Over 1 Year

-47.10%

down

Over 3 Months

-26.80%

down

Over 3 Years

0.00%

down

Over 6 Months

-36.64%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

INDO US BIOTECH LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
29.82%
Promoter Holdings
70.17%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Jagdishkumar Devjibhai Ajudiya 9788924.0 (48.82%) Shareholding of Promoter and Promoter Group
Indo Us Agriseeds Limited 2146824.0 (10.71%) Shareholding of Promoter and Promoter Group
Ajudia Jagdish Devjibhai Huf 1150028.0 (5.74%) Shareholding of Promoter and Promoter Group
Malti Jagdishbhai Ajudia 584122.0 (2.91%) Shareholding of Promoter and Promoter Group
Improwised Technologies Private 400000.0 (1.99%) Public Shareholding
Priyanka Jagdishbhai Ajudia 400000.0 (1.99%) Shareholding of Promoter and Promoter Group
Pratik Rajendrabhai Gandhi 300000.0 (1.5%) Public Shareholding
Aumit Capital Advisors Limited 241000.0 (1.2%) Public Shareholding
Nitin Dalpatlal Shah 213300.0 (1.06%) Public Shareholding
Natvarsinh T Chavda . 203733.0 (1.02%) Public Shareholding
Samarth Nileshbhai Patel 500.0 (0.0%) Shareholding of Promoter and Promoter Group
Hinaben Nileshbhai Patel 500.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

INDO US BIOTECH LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
03 Dec 2024 0.25 Interim 03 Dec 2024 Equity shares
28 Oct 2021 0.25 Interim 29 Oct 2021 Equity shares
Ex-Date Ex-Bonus Ratio
29 Aug 2023 29 Aug 2023 1:1
30 Nov 2021 29 Nov 2021 1:5
24 Apr 2019 23 Apr 2019 1:4
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
28 Oct 2021 0.25 Interim 29 Oct 2021 Equity shares
Ex-Date Ex-Bonus Ratio
29 Aug 2023 29 Aug 2023 1:1
30 Nov 2021 29 Nov 2021 1:5
24 Apr 2019 23 Apr 2019 1:4
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

INDO US BIOTECH LTD Share Price

Indo Us Bio-Tech Limited was originally incorporated as a Private Limited Company with the name 'Pollucid Bio-Tech Private Limited' at Junagadh on February 4, 2004. Subsequently, the name was change to 'Pellucid Bio-Tech Private Limited' on January 5, 2005. Later on, the name of the Company was changed to 'Indo Us Bio-Tech Private Limited' on March 9, 2007. Consequently, upon conversion into Public Limited Company, the name of the Company was changed to 'Indo Us Bio-Tech Limited' on January 11, 2018.

The Company is an ISO 9001-2008 company, involved in crop research & development throw breeding, production of seeds, processing, packing and marketing of high performing hybrid and open pollinated varieties of agricultural crops. The Company has its seed processing plants located in Gujarat, where the seeds are processed, stored and packed with the help of modern machineries. In addition to own processing plant, the Company is also hiring custom seed processing and storage facilities in various states to enable proper supply of seeds in time. Currently Indo US Bio-Tech LTD is one of the fastest growing seed company in India with a large network of over 2500+ distributors and dealers spread across the country.

The Company started its journey way back in 2004, having its own laboratory for seed testing at Junagadh. In laboratory, the company used to test the proportion of Enzyme-Linked Immunosorbent Assay (ELISA) available in the seeds. ELISA tests are primarily used for the detection of proteins in the seeds which helps to fight against the diseases. In the initial stages, the company was mere engaged in the trading of all kind of seeds and mainly agriculture seeds, vegetable seeds, oil seeds etc.

Company has its own Storage Godown of 18000 Sq. ft. which storage capacity is 1500 Tones. Cold storages are key requirements in
the post-harvest storage and distribution function of perishable commodities and food products. It facilitates the delivery of perishable agricultural products from production centers to consumption centers.

As a part of backward integration, the company started In-House Research and Development unit at Modasa, District, Sabarkantha (Gujarat) for research activities to produce better and different varieties of seeds. On September 23, 2011, the company had got the recognition up to March 31, 2014, for In-House R&D from Government of India, Ministry of Science and Technology, Department of Scientific and Industrial Research Technology Bhavan, New Delhi ('DSIR').

In the initial stage at R&D unit, the company was engaged in producing different varieties of oil seeds and pulses seeds, later on the company also added vegetable, spices and cereals seeds to its basket.

At present the company is having collection of around 4460 varieties of germplasm in various crops. The products are being marketed under various brands names like INDO-US 955, INDO-US 936, INDO-US 927 etc.

In January 2018, the Company came up with an Initial Public Offer of 14,30,000 Equity Shares and raised capital aggregating Rs 7.29 Crores.
.

Parent organization Indian Private
NSE symbol INDOUS
Founded 2004
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Indo US Bio-Tech Ltd?

Answer Field

The share price of Indo US Bio-Tech Ltd for NSE is ₹ 147.03 and for BSE is ₹ 153.95.

What is the Market Cap of Indo US Bio-Tech Ltd?

Answer Field

The market cap of Indo US Bio-Tech Ltd for NSE is ₹ 1,34.77 Cr. and for BSE is ₹ 1,41.12 Cr. as of now.

What is the 52 Week High and Low of Indo US Bio-Tech Ltd?

Answer Field

The 52 Week High and Low of Indo US Bio-Tech Ltd for NSE is ₹ 388.40 and ₹ 145.00 and for BSE is ₹ 386.00 and ₹ 147.25.

How to Buy Indo US Bio-Tech Ltd share?

Answer Field

You can trade in Indo US Bio-Tech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Indo US Bio-Tech Ltd?

Answer Field

The 1 year returns on the stock has been -47.10%.

What is the Current Share Price of Indo US Bio-Tech Ltd?

Answer Field

Indo US Bio-Tech Ltd share price is for NSE ₹ 147.03 & for BSE ₹ 153.95 as on Apr 30 2025 03:27 PM.

What is the Market Cap of Indo US Bio-Tech Ltd Share?

Answer Field

The market cap of Indo US Bio-Tech Ltd for NSE ₹ 1,34.77 & for BSE ₹ 1,41.12 as on Apr 30 2025 03:27 PM.

What is the P/E Ratio of Indo US Bio-Tech Ltd Share?

Answer Field

As on Apr 30 2025 03:27 PM the price-to-earnings (PE) ratio for Indo US Bio-Tech Ltd share is 18.54.

What is the PB ratio of Indo US Bio-Tech Ltd Share?

Answer Field

As on Apr 30 2025 03:27 PM, the price-to-book (PB) ratio for Indo US Bio-Tech Ltd share is 35.03.

How to Buy Indo US Bio-Tech Ltd Share?

Answer Field

You can trade in Indo US Bio-Tech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Indo US Bio-Tech Ltd Share on Bajaj Broking App?

Answer Field

To buy Indo US Bio-Tech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Indo US Bio-Tech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|